Warning Letter

Case 630105 — FEI 3003159106

Action Details

Facility
Aspire Pharmaceuticals, Inc.
Date
November 22, 2022
Fiscal Year
2023
Product Type
Drugs
Center
CDER
Location
Somerset, NJ (United States)